You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 268 No. 8, August 26, 1992 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contributions
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Effect of a Media Blitz and a Threatened Lawsuit on Stimulant Treatment

Daniel J. Safer, MD; John M. Krager, MD, MPH

JAMA. 1992;268(8):1004-1007.


Abstract

Objective.
—To enumerate and evaluate changes in the rate of medication treatment for hyperactive/inattentive students subsequent to negative media publicity about methylphenidate (Ritalin) and related lawsuits threatened or initiated from late 1987 to early 1989.

Design.
—Biennial 1971 to 1991 school nurse surveys of medication treatment for hyperactive/inattentive students; a 1989 school nurse questionnaire on parent attitudes about medication; annual 1984 through 1991 hyperkinetic clinic treatment data; annual 1986 through 1990 Drug Enforcement Administration estimates of retail sales of methylphenidate, nationally and locally.

Primary Setting.
—All public and private elementary and secondary schools in Baltimore County, Maryland.

Patients.
—Students receiving medication for hyperactivity/inattentiveness.

Results.
—Whereas the medication rate for the treatment of hyperactive/ inattentive students in Baltimore County doubled every 4 to 7 years from 1971 through 1987, it declined 39% in the 1989 and 1991 surveys from its 1987 peak. This drop occurred after the 1987 through 1989 media blitz against methylphenidate and after a well-publicized threatened lawsuit locally. Parents became fearful of media-reported medication "side effects" and school staff hesitated to refer restless, impulsive, and inattentive students to physicians. Most inhibited from the prospect of medication treatment were less affluent parents and parents of hyperactive/inattentive elementary schoolchildren who had never received medication. Drug Enforcement Administration data revealed that the Baltimore metropolitan area had a far greater decline in methylphenidate use than that which occurred nationally.

Conclusion.
—Strong circumstantial evidence suggests that the prominent 1989 and 1991 declines in the initiation of stimulant medication for hyperactive/inattentive students were related to the apprehension of parents and involved professionals generated by the methylphenidate media blitz and the threatened lawsuit.

(JAMA. 1992;268:1004-1007)



Author Affiliations

From the Baltimore County Department of Health and The Johns Hopkins University School of Medicine, Baltimore, Md.


Footnotes

Reprint requests to Baltimore County Department of Health, 9100 Franklin Square Dr, Baltimore, MD 21237 (Dr Safer).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Attention Deficit Hyperactivity Disorder: Comorbidity and Medication Use
Kube et al.
CLIN PEDIATR 2002;41:461-469.
ABSTRACT  

Pediatric Stimulant and Selective Serotonin Reuptake Inhibitor Prescription Trends: 1992 to 1998
Rushton and Whitmire
Arch Pediatr Adolesc Med 2001;155:560-565.
ABSTRACT | FULL TEXT  

National Trends in the Prevalence of Attention-Deficit/Hyperactivity Disorder and the Prescribing of Methylphenidate among School-Age Children: 1990-1995
Robison et al.
CLIN PEDIATR 1999;38:209-217.
ABSTRACT  

Diagnosis and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
Goldman et al.
JAMA 1998;279:1100-1107.
ABSTRACT | FULL TEXT  

Pediatricians' Knowledge and Attitudes Concerning Diagnosis and Treatment of Attention Deficit and Hyperactivity Disorders: A National Survey Approach
Kwasman et al.
Arch Pediatr Adolesc Med 1995;149:1211-1216.
ABSTRACT  

The Role of Methylphenidate in Psychiatry
Klein and Wender
Arch Gen Psychiatry 1995;52:429-433.
ABSTRACT  

Is Methylphenidate Like Cocaine? Studies on Their Pharmacokinetics and Distribution in the Human Brain
Volkow et al.
Arch Gen Psychiatry 1995;52:456-463.
ABSTRACT  

The Use of Methylphenidate in Michigan
Rappley et al.
Arch Pediatr Adolesc Med 1995;149:675-679.
ABSTRACT  

A National Survey of Public Health Officers' Interactions With the Media
Gellert et al.
JAMA 1994;271:1285-1289.
ABSTRACT  

The Impact of Recent Lawsuits on Methylphenidate Sales
Safer
CLIN PEDIATR 1994;33:166-168.
 

Treatment of Attention-Deficit Hyperactivity Disorder
Vatz and Weinberg
JAMA 1993;269:2368-2368.
ABSTRACT  

Treatment of Attention-Deficit Hyperactivity Disorder
Baughman
JAMA 1993;269:2368-2369.
ABSTRACT  

TV or Not TV Communicating Health Information to the Public
Dan
JAMA 1992;268:1026-1027.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1992 American Medical Association. All Rights Reserved.